Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Nexstim Targets US Stroke Rehab Market With Noninvasive Navigated Brain Therapy

This article was originally published in Clinica

Executive Summary

Finnish noninvasive brain stimulation company Nexstim is eyeing the US as its initial sales market once it completes phase III trial of its Navigated Brain Therapy (NBT) for post-acute stroke treatment.